Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2009,NCI,5R01CA113969-05,,RhoH GTPase in Hematopoiesis and Cancer,"WILLIAMS, DAVID",CHILDREN'S HOSPITAL BOSTON,MA,"$318,664"
Lymphoma,2009,NIAID,9R01AI079732-06,,Accessibility Control of Antigen Receptor Gene Assembly,"OLTZ, EUGENE",VANDERBILT UNIVERSITY,TN,"$208,750"
Lymphoma,2009,NIGMS,5R37GM032741-27,,INTRACHROMOSOMAL RECOMBINATION IN MAMMALIAN CELLS,"LISKAY, ROBERT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$364,729"
Lymphoma,2009,NCI,5R01CA116093-03,,Effects of human SWI/SNF-associated PRMT5 on lymphomagenesis,"SIF, SAID",OHIO STATE UNIVERSITY,OH,"$256,500"
Lymphoma,2009,NCI,5R01CA124621-03,,Role of Arsenic Trioxide in Primary Effusion Lymphoma,"CHAUDHARY, PREET",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$278,239"
Lymphoma,2009,NCI,5F32CA123777-04,,Understanding the Role of Autophagy in Cancer,"DORSEY, FRANK",SCRIPPS RESEARCH INSTITUTE,CA,"$53,354"
Lymphoma,2009,NIAID,5K22AI070317-02,,Essential role of transcription factor Foxp1 in B cell development and function,"HU, HUI",WISTAR INSTITUTE,PA,"$108,000"
Lymphoma,2009,NIAID,5R21AI073627-02,,Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine,"SNAPPER, CLIFFORD",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$230,850"
Lymphoma,2009,NCI,5R01CA084069-10,,Mechanisms of Cell Cycle Associated Neoplasia,"CLURMAN, BRUCE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$348,574"
Lymphoma,2009,NIAID,5R01AI018757-27,,Host Immunity to EBV Infection in Vitro and in VIvo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$411,979"
Lymphoma,2009,NCI,5R01CA033192-22,,Transformation by Reticuloendotheliosis Virus,"BOSE, HENRY",UNIVERSITY OF TEXAS AUSTIN,TX,"$302,402"
Lymphoma,2009,NCI,5R01CA076287-11,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$364,467"
Lymphoma,2009,NIAID,5R01AI063345-04,,Trophic Regulation in T Cell Homeostasis and Disease,"RATHMELL, JEFFREY",DUKE UNIVERSITY,NC,"$371,495"
Lymphoma,2009,NCI,5R01CA122539-02,,Lymphoproliferative Disorders in Primary Immunodeficiencies,"ROUTES, JOHN",MEDICAL COLLEGE OF WISCONSIN,WI,"$314,363"
Lymphoma,2009,NCI,5R01CA106662-05,,Dendritic Cell Threapy for Cutaneous T-Cell Lymphoma,"FALO, LOUIS",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$288,651"
Lymphoma,2009,NCI,5R01CA125658-03,,Rac GTPases as Targets in Lymphomagenesis,"ZHENG, YI",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$285,000"
Lymphoma,2009,NIAID,5R01AI063058-05,,Roles of the Artemis nuclease in DNA repair and disease,"SEKIGUCHI, JOANN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$279,700"
Lymphoma,2009,NCI,5R01CA070723-13,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$293,829"
Lymphoma,2009,NIAID,5R01AI061017-05,,Epstein-Barr virus glycoproteins and virus spread,"HUTT-FLETCHER, LINDSEY",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$303,468"
Lymphoma,2009,NCI,5R01CA093237-08,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, J",UNIVERSITY OF PENNSYLVANIA,PA,"$291,081"
Lymphoma,2009,NCI,5R01CA095431-05,,Regulation of the Tp12 Kinase,"TSICHLIS, PHILIP",TUFTS MEDICAL CENTER,MA,"$274,719"
Lymphoma,2009,NCI,5R01CA124332-03,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$277,400"
Lymphoma,2009,NIAID,5R01AI076183-07,,Structural and Functional Studies of gp42 and HLA Class II in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$416,143"
Lymphoma,2009,NCI,5R01CA121180-04,,A Comprehensive Investigation of Viral-induced Lymphomagenesis,"FISHER, SUSAN",UNIVERSITY OF ROCHESTER,NY,"$268,080"
Lymphoma,2009,NCI,5R01CA100053-05,,Cell Autonomy and Tumor Suppression by CDK inhibitors,"FERO, MATTHEW",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$351,072"
Lymphoma,2009,NCI,5R01CA119066-04,,Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2,"LOOK, A",DANA-FARBER CANCER INSTITUTE,MA,"$303,525"
Lymphoma,2009,NCI,5R01CA031534-25,,MAR Mediated Control of The IgH Enhancer,"TUCKER, PHILIP",UNIVERSITY OF TEXAS AUSTIN,TX,"$257,359"
Lymphoma,2009,NIDDK,5K01DK080894-02,,DNA EXCHANGE DURING STOMACH COLONIZATION BY HELICOBACTER PYLORI,"DORER, MARION",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$100,402"
Lymphoma,2009,NCI,5R37CA042245-24,,Regulation of replication and latency EBV EBNAs,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$367,373"
Lymphoma,2009,NCI,5R01CA091791-08,,Reactivation of Kaposi's sarcoma-associated herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$281,463"
Lymphoma,2009,NCI,1R15CA136901-01,,Macrophage Density Regulates T Cells,"RIGGS, JAMES",RIDER UNIVERSITY,NJ,"$198,573"
Lymphoma,2009,NCI,1R01CA136905-01,,Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$289,184"
Lymphoma,2009,NCI,1R01CA136895-01,,Molecular targets in diffuse large B cell lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$276,224"
Lymphoma,2009,NCI,5R01CA077553-10,,Mechanism of T cell lymphoma in E protein deficiency,"SUN, XIAO-HONG",OKLAHOMA MEDICAL RESEARCH FOUNDATION,OK,"$288,329"
Lymphoma,2009,NCI,1R01CA137123-01,,Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle,"TAO, JIANGUO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$276,390"
Lymphoma,2009,NCI,5R01CA030356-28,,EBV Genome Expression:Localization of Specific Functions,"HAYWARD, S",JOHNS HOPKINS UNIVERSITY,MD,"$330,440"
Lymphoma,2009,NCI,5R01CA118559-03,,IN VIVO 31P MRS STUDIES OF NON-HODGKIN'S LYMPHOMA,"BROWN, TRUMAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,203,971"
Lymphoma,2009,NCI,5K99CA131474-02,,Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells,"NEILSON, JOEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$138,105"
Lymphoma,2009,NCI,5R01CA120185-03,,c-Myc-regulated microRNAs in normal and pathologic cellular physiology,"MENDELL, JOSHUA",JOHNS HOPKINS UNIVERSITY,MD,"$309,168"
Lymphoma,2009,NHLBI,5K08HL091517-02,,Annexin 2 in Lymphoproliferative Angiogenesis,"RUAN, JIA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$131,490"
Lymphoma,2009,NCI,5R01CA066519-15,,EBV-based Strategies for AIDS-related Malignancies,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$391,101"
Lymphoma,2009,NIAID,5R01AI064345-05,,Role of RNA silencing in B cell development and function,"RAJEWSKY, KLAUS","IMMUNE DISEASE INSTITUTE, INC.",MA,"$649,908"
Lymphoma,2009,NCI,5R01CA085573-09,,Role of the BCL 6 Proto Oncogene in B Cell Lymphomas,"YE, BIHUI",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$357,886"
Lymphoma,2009,NCI,5R01CA130752-02,,Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$309,175"
Lymphoma,2009,NCI,5R01CA117935-03,,p53-Independent Pathways in Mdm2-Mediated Transformation,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$329,378"
Lymphoma,2009,NCI,5R01CA089305-08,,MYC's Role in the Initiation and Maintenance of Cancer,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$391,431"
Lymphoma,2009,NCI,1R15CA137608-01,,The Role of Mismatch Repair Factors in Class Switch Recombination,"LARSON, ERIK",ILLINOIS STATE UNIVERSITY,IL,"$213,750"
Lymphoma,2009,NIAID,5R01AI060729-05,,Stage-specific Signaling in Peripheral B Cell Selection,"KHAN, WASIF",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$364,351"
Lymphoma,2009,NCI,7R01CA100555-05,,Lymphoma Defined Cytogenetically for Epidemiologic Study,"CHIU, BRIAN",UNIVERSITY OF CHICAGO,IL,"$219,753"
Lymphoma,2009,NCI,1R01CA132840-01A1,,Function of REV3L in limiting oncogenesis via DNA damage tolerance,"WOOD, RICHARD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Lymphoma,2009,NCI,5R01CA129132-02,,Development of cambinol analogues as antilymphoma agents,"BEDALOV, ANTONIO",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$365,200"
Lymphoma,2009,NIAID,5R01AI041769-12,,Cellular Mechanisms of PTLD in Transplant Recipients,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$353,157"
Lymphoma,2009,NCI,2R01CA078384-11,,E2A as a Tumor Suppressor,"MURRE, CORNELIS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$402,282"
Lymphoma,2009,NIBIB,5R01EB002991-06,,Biofunctional Polymers for Intracellular Drug Delivery,"STAYTON, PATRICK",UNIVERSITY OF WASHINGTON,WA,"$501,491"
Lymphoma,2009,NCI,5R01CA108951-05,,Oncogenic properties of interferon regulatory factor 7,"ZHANG, LUWEN",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$217,243"
Lymphoma,2009,NCI,2R01CA102705-06A1,,Mismatch repair in V region mutation and isotype switching,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$324,645"
Lymphoma,2009,NCI,5R01CA117827-05,,Function of the Epstein-Barr Virus EBNA-A3 Protein,"SAMPLE, CLARE",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$251,214"
Lymphoma,2009,NCI,2R01CA077429-10A2,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$418,237"
Lymphoma,2009,NIAID,1R01AI077533-01A1,,Regulation of Immunity and Inflammation by TIPE2,"CHEN, YOUHAI",UNIVERSITY OF PENNSYLVANIA,PA,"$393,750"
Lymphoma,2009,NCI,5R01CA124311-03,,"Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$254,790"
Lymphoma,2009,NCI,5R37CA012055-37,,Studies of Epstein-Barr Virus,"MILLER, I.",YALE UNIVERSITY,CT,"$453,975"
Lymphoma,2009,NCI,1R01CA131354-01A1,,Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$365,892"
Lymphoma,2009,NCI,1R01CA129560-01A2,,Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas,"HAQUE, AZIZUL",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$300,543"
Lymphoma,2009,NCI,2P01CA078902-11,8825,Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$222,005"
Lymphoma,2009,NIAID,1R01AI072194-01A2,,ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$474,000"
Lymphoma,2009,NCI,1K08CA133521-01A1,,Role of B-cell oncogenes and microRNA-34 in B-lymphopoiesis and neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$151,632"
Lymphoma,2009,FIC,5R03TW007821-02,,Micronutrient Malnutrition and EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$39,031"
Lymphoma,2009,NCI,2R01CA100603-07A1,,Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer,"CLEVELAND, JOHN",SCRIPPS RESEARCH INSTITUTE,CA,"$422,647"
Lymphoma,2009,NCI,5R01CA073507-12,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$499,500"
Lymphoma,2009,NCI,1R21CA133781-01A1,,DNA Damage Responses in B Cell Development,"MANIS, JOHN",CHILDREN'S HOSPITAL BOSTON,MA,"$221,198"
Lymphoma,2009,NIAID,5R01AI068907-02,,"Transcriptional Control of Th-POK, a Key Regulator of Lineage Control","KAPPES, DIETMAR",INSTITUTE FOR CANCER RESEARCH,PA,"$490,952"
Lymphoma,2009,NCI,5R37CA054281-17,,Multiethnic Cohort Study of Diet and Cancer,"KOLONEL, LAURENCE",UNIVERSITY OF HAWAII AT MANOA,HI,"$2,331,768"
Lymphoma,2009,NIGMS,5R01GM048026-17,,V(D)J Recombination Activating Genes-Functional Analysis,"OETTINGER, MARJORIE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$399,324"
Lymphoma,2009,NCI,2R01CA096856-06A2,,Novel role of STAT3 in NPM/ALK-induced oncogenesis,"WASIK, MARIUSZ",UNIVERSITY OF PENNSYLVANIA,PA,"$299,362"
Lymphoma,2009,NCI,5R01CA116933-03,,Preventing Tumorigenesis in Developing Lymphocytes,"ZHU, CHENGMING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Lymphoma,2009,NIDDK,5K01DK074555-04,,Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2,"JETTE, CICELY",DANA-FARBER CANCER INSTITUTE,MA,"$133,110"
Lymphoma,2009,NHLBI,5R01HL088686-02,,Modeling B cell Lymphoma in the Mouse,"RICKERT, ROBERT",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$477,500"
Lymphoma,2009,NCI,5P01CA094237-07,,Enhancing T Cell Therapy of Cancer,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$1,961,712"
Lymphoma,2009,NCI,5R01CA128941-02,,Regulatory T cells in B cell lymphoma,"LEVITSKY, HYAM",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Lymphoma,2009,NCI,5R01CA113872-05,,Role of OCA-B in B cell differentiation and malignancy,"ROEDER, ROBERT",ROCKEFELLER UNIVERSITY,NY,"$539,598"
Lymphoma,2009,NCI,5R01CA083823-08,,Selective Forces Operative in FeLV Infection,"LEVY, LAURA",TULANE UNIVERSITY OF LOUISIANA,LA,"$268,582"
Lymphoma,2009,NCI,5R01CA111807-05,,The Role of Toll-Like Receptors in Cancer Immunotherapy,"YANG, YIPING",DUKE UNIVERSITY,NC,"$288,390"
Lymphoma,2009,NIDCR,5R01DE018304-03,,ART Modulation of Viral Pathogenesis in Oral Epithelia,"DITTMER, DIRK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$317,667"
Lymphoma,2009,NIAID,1R43AI078577-01A1,,miRNA HD Array Platform,"SELIGMANN, BRUCE","HIGH THROUGHPUT GENOMICS, INC.",AZ,"$516,831"
Lymphoma,2009,NCI,1R01CA137894-01,,EBV Antigen and Cell Cycle Regulation,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$294,131"
Lymphoma,2009,NCI,5R01CA092229-09,,Helicobacter Host Interactions in Animal Models,"AMIEVA, MANUEL",STANFORD UNIVERSITY,CA,"$283,233"
Lymphoma,2009,NCI,5R01CA071540-12,,Molecular Basis of Action of the Putative Oncogene BCL-6,"BARDWELL, VIVIAN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$311,124"
Lymphoma,2009,NIBIB,5R01EB001994-10,,SPECT/CT Image-Based Dosimetry in Radionuclide Tharapy,"DEWARAJA, YUNI",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$340,393"
Lymphoma,2009,NIAID,1F32AI078625-01A1,,Kaposi's Sarcoma-Associated Herpesvirus (KSHV) evasion of Natural Killer cells,"MADRID, ALEXIS",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$51,710"
Lymphoma,2009,NIAID,1P01AI076210-01A1,8138,Role of SAP (SH2D1A) gene in T cell-dependent antibody response,"TERHORST, CORNELIS",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$300,968"
Lymphoma,2009,NIAID,1P01AI076210-01A1,8139,Role of TACI mutations in CVID,"GEHA, RAIF",CHILDREN'S HOSPITAL BOSTON,MA,"$476,106"
Lymphoma,2009,NIA,5R01AG026661-04,,Role of RecQ Helicases to Prevent Senescence By c-Myc,"GRANDORI, CARLA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$303,731"
Lymphoma,2009,NCI,5R01CA109697-05,,Herpesvirus saimiri TIP,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$299,169"
Lymphoma,2009,NHLBI,1F30HL095287-01,,Infection of primary B cells by the human lymphomagenic pathogen HHV8,"HASSMAN, LYNN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$27,636"
Lymphoma,2009,NCI,5R01CA075922-13,,Rhesus HHV-8 homologue in AIDS-related malignancies,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$611,550"
Lymphoma,2009,NCI,5R01CA068051-14,,Pathogenesis of Epstein-Barr Virus Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$417,501"
Lymphoma,2009,NCI,2R01CA052004-20A2,,Control of Gammaherpesvirus Replication,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$320,153"
Lymphoma,2009,NCI,5R01CA132638-02,,Anti-viral IL6 approach to mitigate KSHV-related disease,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$680,879"
Lymphoma,2009,NCI,5R01CA085888-10,,Malignant Complications of Chronic HCV,"LOFFREDO, CHRISTOPHER",GEORGETOWN UNIVERSITY,DC,"$295,888"
Lymphoma,2009,NCI,5R01CA071796-12,,Multistep Lymphomagenesis/Tumorigenesis in Transgenic Mice: Protein Kinase Ck2,"SELDIN, DAVID",BOSTON MEDICAL CENTER,MA,"$275,767"
Lymphoma,2009,NCI,5R01CA133027-02,,"EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors","SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$300,378"
Lymphoma,2009,NIAID,5R21AI076720-02,,Wnt/b-catenin signaling in T-cell transformation,"GOUNARI, FOTINI",UNIVERSITY OF CHICAGO,IL,"$230,250"
Lymphoma,2009,NCI,5R01CA102667-05,,Effects of Malaria on EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$269,426"
Lymphoma,2009,NCI,5R01CA127238-03,,Herpesvirus-induced telomerase dysregulation and tumor formation,"JAROSINSKI, KEITH",CORNELL UNIVERSITY ITHACA,NY,"$228,684"
Lymphoma,2009,NCI,5R01CA114416-04,,Epstein-Barr Virus-Enhanced Tumor Progression,"SCOTT, RONA",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$283,896"
Lymphoma,2009,NCI,5R01CA102646-05,,USE OF mTOR INHIBITORS IN B CELL LEUKEMIA,"GRUPP, STEPHAN",CHILDREN'S HOSPITAL OF PHILADELPHIA,PA,"$320,964"
Lymphoma,2009,NCI,5T32CA009140-35,,Immunobiology of normal and neoplastic lymphocytes,"PATERSON, YVONNE",UNIVERSITY OF PENNSYLVANIA,PA,"$651,130"
Lymphoma,2009,NCI,5U10CA016116-36,,Eastern Cooperative Oncology Group,"FORASTIERE, ARLENE",JOHNS HOPKINS UNIVERSITY,MD,"$284,348"
Lymphoma,2009,NCI,5K22CA113493-03,,Role of MAP kinases in anaplastic large cell lymphoma,"ZU, YOULI",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$151,200"
Lymphoma,2009,NCI,5K23CA124465-02,,Novel Biologic Therapies for Hodgkin's Lymphoma,"KASAMON, YVETTE",JOHNS HOPKINS UNIVERSITY,MD,"$140,940"
Lymphoma,2009,NCI,5R01CA058524-15,,Regulation of EBV Transcription in Burkitt's Lymphoma,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$272,412"
Lymphoma,2009,NCI,5R01CA068682-19,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN",UNIVERSITY OF TEXAS AUSTIN,TX,"$305,354"
Lymphoma,2009,NCI,5K22CA120147-03,,Interaction of TCL1 with a novel exoribonuclease,"FRENCH, SAMUEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$152,820"
Lymphoma,2009,NCI,5R01CA114504-05,,PRDI-BF1 and histone methyltransferase in lymphoma,"WRIGHT, KENNETH",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$230,795"
Lymphoma,2009,NCI,5K23CA123149-03,,Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy,"NEELAPU, SATTVA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$136,080"
Lymphoma,2009,NCI,5R01CA113518-04,,Tetravalent antibodies with altered FcRn binding sites,"SMALLSHAW, JOAN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$173,790"
Lymphoma,2009,NCI,5R01CA085177-10,,"Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig","CHAUDHARY, PREET",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$236,627"
Lymphoma,2009,NIAID,5R01AI076972-03,,Programming of CD8+ T Cell Tolerance by B Cell APC,"SCHOENBERGER, STEPHEN",LA JOLLA INST FOR ALLERGY & IMMUNOLGY,CA,"$613,334"
Lymphoma,2009,NCI,5R01CA113794-05,,"The function of Snf5, an epigenetic tumor suppressor","ROBERTS, CHARLES",DANA-FARBER CANCER INSTITUTE,MA,"$320,225"
Lymphoma,2009,NCI,5K23CA113775-04,,Proteosome Inhibition Therapy for Hematologic Malignancy,"HORTON, TERZAH",BAYLOR COLLEGE OF MEDICINE,TX,"$134,015"
Lymphoma,2009,NIEHS,1P42ES016465-01A1,6110,Project 1: Environmental PAH Mixtures as Skin and Transplacental Carcinogens,"BAIRD, WILLIAM",OREGON STATE UNIVERSITY,OR,"$311,857"
Lymphoma,2009,NCI,5R01CA125195-03,,Molecular Pathways in Suppression and Development of T Lineage Lymphomas,"BASSING, CRAIG",CHILDREN'S HOSPITAL OF PHILADELPHIA,PA,"$312,550"
Lymphoma,2009,NCI,5R03CA135528-02,,Characterization of Atmtm1Awb Congenic Strains,"WEIL, MICHAEL",COLORADO STATE UNIVERSITY-FORT COLLINS,CO,"$73,500"
Lymphoma,2009,NIEHS,5R01ES015707-03,,Comparative Mechanisms of Genomic Instability,"VASQUEZ, KAREN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$358,435"
Lymphoma,2009,NCI,5R37CA037295-26,,AIDS Associated Lymphoproliferative Disorders,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$402,500"
Lymphoma,2009,NCI,5R01CA071768-13,,Redox Control of Apoptosis Signaling,"BRIEHL, MARGARET",UNIVERSITY OF ARIZONA,AZ,"$221,264"
Lymphoma,2009,NCI,5R01CA088768-10,,Structure and Molecular Composition of KSHV and RRV,"KEDES, DEAN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$476,141"
Lymphoma,2009,NCI,5R01CA106705-05,,Cyclic AMP-mediated apoptosis in lymphoid malignancies,"LERNER, ADAM",BOSTON MEDICAL CENTER,MA,"$241,199"
Lymphoma,2009,NCI,5F31CA134209-02,,microRNAs Dysregulated by HMG-I in Neoplastic Transformation,"SMAIL, SHAMAYRA",JOHNS HOPKINS UNIVERSITY,MD,"$41,176"
Lymphoma,2009,NCI,5R01CA113579-05,,Role and therapeutical potential of Cdk4/6 in B-lymphoma,"ZOU, XIANGHONG",OHIO STATE UNIVERSITY,OH,"$193,715"
Lymphoma,2009,NCI,5R01CA121039-03,,B Cell Lymphoma Therapy,"CHOI, YONG",OCHSNER CLINIC FOUNDATION,LA,"$244,245"
Lymphoma,2009,NCI,5R13AI066870-05,,"Lymphocytes and the Immune System Molecular, Cellular and Interactive Mechanisms","ROTHENBERG, ELLEN",FEDERATION OF AMER SOC FOR EXPER BIOLOGY,MD,"$3,000"
Lymphoma,2009,NIAID,5R13AI066870-05,,"Lymphocytes and the Immune System Molecular, Cellular and Interactive Mechanisms","ROTHENBERG, ELLEN",FEDERATION OF AMER SOC FOR EXPER BIOLOGY,MD,"$10,999"
Lymphoma,2009,NCI,5R01CA122645-02,,Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$319,918"
Lymphoma,2009,NCI,5R01CA124309-04,,Role of PML nuclear body proteins for establishment of EBV latent infection,"LING, PAUL",BAYLOR COLLEGE OF MEDICINE,TX,"$258,530"
Lymphoma,2009,NCI,1R21CA138373-01,,Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago,"YIN, HANG",UNIVERSITY OF COLORADO AT BOULDER,CO,"$164,189"
Lymphoma,2009,NCI,1R21CA138359-01,,"Ultrahigh sensitive, personalized monitoring of lymphoma relapse using blood spec","YEN, YUN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$219,120"
Lymphoma,2009,NCI,5K23CA109613-05,,Targeting the Mitochondria to Treat Lymphoma and Myeloma,"EVENS, ANDREW",NORTHWESTERN UNIVERSITY,IL,"$131,445"
Lymphoma,2009,NCI,5R01CA106159-05,,Role of Epstein-Barr virus LMP1 in lymphoma,"IZUMI, KENNETH",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$218,727"
Lymphoma,2009,NCI,5R01CA083937-07,,Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis,"GELINAS, CELINE",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$247,664"
Lymphoma,2009,NCI,5U01CA114778-05,,Molecular Signatures to Improve Diagnosis and Outcome Pr,"CHAN, WING",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$1,720,841"
Lymphoma,2009,NCI,5R01CA096500-08,,Role of KSHV K1 in viral pathogenesis,"DAMANIA, BLOSSOM",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$279,757"
Lymphoma,2009,NCI,5R01CA134051-02,,T Cell Immunity in Endemic Burkitt Lymphoma,"MOORMANN, ANN",CASE WESTERN RESERVE UNIVERSITY,OH,"$493,967"
Lymphoma,2009,NCI,5R01CA068939-12,,Survival Signals in AIDS Lymphomas,"CESARMAN, ETHEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$458,900"
Lymphoma,2009,NIAID,1R21AI082329-01,,A novel method to identify interacting partners of insoluble proteins,"PAPAVASILIOU, F.",ROCKEFELLER UNIVERSITY,NY,"$253,000"
Lymphoma,2009,NCI,1R21CA139368-01,,"Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100","BAUM, LINDA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$203,280"
Lymphoma,2009,NIAID,5R21AI079373-02,,Deletion of inhibitory genes in post-thymic T cells to study immune tolerance,"GAJEWSKI, THOMAS",UNIVERSITY OF CHICAGO,IL,"$192,500"
Lymphoma,2009,NCI,2R01CA099997-06A2,,Mechanisms of Alteration of B Lymphocyte Function by LMP1,"BISHOP, GAIL",UNIVERSITY OF IOWA,IA,"$335,425"
Lymphoma,2009,NCI,5R01CA113454-04,,Targeted Gene Therapy for Lymphoma,"SMITH, BRUCE",AUBURN UNIVERSITY AT AUBURN,AL,"$263,186"
Lymphoma,2009,NCI,5R01CA108609-06,,Anti-viral DC/NK interactions,"MUNZ, CHRISTIAN",UNIVERSITY OF ZURICH,SWITZE,"$182,434"
Lymphoma,2009,NCI,5R01CA128803-03,,Identifying determinants of chemotherapeutic response in vivo,"HEMANN, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$282,545"
Lymphoma,2009,NCI,5R01CA131027-02,,Chimeric T Cell for Therpay of Hodgkin Disease,"SAVOLDO, BARBARA",BAYLOR COLLEGE OF MEDICINE,TX,"$318,513"
Lymphoma,2009,NIAID,1R01AI078980-01A1,,Motor protein regulation of T cell receptor signaling,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$410,000"
Lymphoma,2009,NIDCR,5R01DE011390-22,,Regulation of Immunity by Prostaglandins,"PHIPPS, RICHARD",UNIVERSITY OF ROCHESTER,NY,"$354,752"
Lymphoma,2009,NCI,2R01CA098285-06A1,,Towards a Mouse Model of Classical Hodgkin's Disease and PTLD,"RAJEWSKY, KLAUS","IMMUNE DISEASE INSTITUTE, INC.",MA,"$487,828"
Lymphoma,2009,NIAID,5R21AI079800-02,,Altered somatic mutation in IgAD/CVID; association with deficiency of Msh4/5,"SEKINE, HIDEHARU",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$184,375"
Lymphoma,2009,NCI,5K23CA115682-05,,Genetic Alterations in Families with Multiple Lymphomas,"BROWN, JENNIFER",DANA-FARBER CANCER INSTITUTE,MA,"$136,890"
Lymphoma,2009,NIDCR,2R01DE017336-04A2,,Epigenetic Regulation of Epstein-Barr Virus Latency Programs,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$324,562"
Lymphoma,2009,NCI,1R01CA131024-01A2,,The Role of Methylthioadenosine Phosphorylase Loss in Tumorigenesis,"KRUGER, WARREN",FOX CHASE CANCER CENTER,PA,"$361,742"
Lymphoma,2009,NCI,5R21CA133876-02,,Clinical Activity of MGCD-0103 in Hodgkin Lymphoma,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$250,200"
Lymphoma,2009,NCI,1R01CA129682-01A2,,Regulation of Autophagy and Tumorigenesis by Bif-1,"WANG, HONG-GANG",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$321,313"
Lymphoma,2009,NIDCR,5R01DE018926-03,,Pathogenesis of oral rhesus lymphocryptovirus infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$374,562"
Lymphoma,2009,NCI,2R01CA101700-05A2,,1H NMR STUDIES OF NON-HODGKINS LYMPHOMA,"GLICKSON, JERRY",UNIVERSITY OF PENNSYLVANIA,PA,"$357,353"
Lymphoma,2009,NHLBI,5R01HL064851-09,,New EBV Therapies for treating malignancies,"PAGANO, JOSEPH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$346,086"
Lymphoma,2009,NCI,5R01CA093729-08,,Repair of Genome Destabilizing DNA Structures,"VASQUEZ, KAREN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$307,161"
Lymphoma,2009,NCI,5R01CA121195-04,,Prediagnostic Markers of Immune Activation and Viral Infection and Risk of NHL,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$392,020"
Lymphoma,2009,NCI,5R01CA133063-02,,Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY,IL,"$274,204"
Lymphoma,2009,NCI,5R01CA057152-15,,Immune Dysfunction and AIDS-associated B Cell Lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$279,804"
Lymphoma,2009,NCI,5R03CA125827-02,,Space-Time Clustering of Non-Hodgkin's Lymphoma Using Residential Histories,"MELIKER, JAYMIE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$84,368"
Lymphoma,2009,NCI,5R01CA115665-04,,Molecular Mechanisms of Lymphomagenesis,"MILLS, KEVIN",JACKSON LABORATORY,ME,"$289,553"
Lymphoma,2009,NCI,5K07CA108565-04,,QOL and Service Needs of Leukemia/Lymphoma Survivors,"PARRY, CARLA",UNIVERSITY OF COLORADO DENVER,CO,"$134,321"
Lymphoma,2009,NCI,5R01CA093853-07,,The role of p63 and p73 in cancer,"MOLL, UTE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$312,641"
Lymphoma,2009,NCI,1R03CA135687-01A1,,"Vitamin D, alcohol, and risk of lymphomas in a prospective cohort of women","CHANG, ELLEN",NORTHERN CALIFORNIA CANCER CENTER,CA,"$72,500"
Lymphoma,2009,NIAID,1R03AI081021-01A1,,Rapid FISH Detection of EBV-infected Cells,"STOWE, RAYMOND","MICROGEN, LLC",TX,"$77,500"
Lymphoma,2009,NCI,1R21CA135523-01A2,,Cancer prevention by indole-3-carbinol via modulation of the epigenome,"BENNINGHOFF, ABBY",OREGON STATE UNIVERSITY,OR,"$160,820"
Lymphoma,2009,NCI,5R01CA090571-08,,TCL1 Oncogene in B Lymphocyte Development and Neoplasia,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$266,199"
Lymphoma,2009,NIDCR,5R01DE019249-02,,Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma,"ELENITOBA-JOHNSON, KOJO",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$386,250"
Lymphoma,2009,NIDCR,5R21DE017136-02,,Sjogren's Syndrome Associated B-cell lymphomagenesis,"BAHLER, DAVID",UNIVERSITY OF UTAH,UT,"$150,795"
Lymphoma,2009,NCI,5R01CA121935-04,,Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings,"BARBER, GLEN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$248,486"
Lymphoma,2009,NCI,5R01CA109524-04,,IL-7 and Lymphocyte Homeostasis: Life versus Death,"KHALED, ANNETTE",UNIVERSITY OF CENTRAL FLORIDA,FL,"$195,792"
Lymphoma,2009,NCI,5R01CA056764-15,,Activation of BCL-2 in Hematologic Malignancies,"BOXER, LINDA","PALO ALTO INSTITUTE FOR RES & EDU, INC.",CA,"$290,500"
Lymphoma,2009,NCI,5R01CA108872-04,,Dysregulation of ubiquitination in MALT lymphomas,"YANG, XIAOLU",UNIVERSITY OF PENNSYLVANIA,PA,"$244,309"
Lymphoma,2009,NCI,5R01CA092660-09,,Lymphocyte Survival: Implications for lymphomagenesis,"THOMPSON, CRAIG",UNIVERSITY OF PENNSYLVANIA,PA,"$310,988"
Lymphoma,2009,NCI,5R21CA128501-03,,High affinity ligand to deliver nanoparticle drugs to lymphoid cancers,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$152,000"
Lymphoma,2009,NCI,5R01CA085721-10,,Experimental Therapy of Cancer by Costimulated Immunity,"CHEN, LIEPING",JOHNS HOPKINS UNIVERSITY,MD,"$325,256"
Lymphoma,2009,NCI,5R33CA103548-04,,PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS,"JAY, DANIEL",TUFTS UNIVERSITY BOSTON,MA,"$585,012"
Lymphoma,2009,NHLBI,5R01HL076799-06,,"Inflammatory Proteases, Ubiquitin Proteasome System, and Myocyte Death","SABRI, ABDELKARIM",TEMPLE UNIVERSITY,PA,"$375,000"
Lymphoma,2009,NCI,5R01CA122663-04,,A Genome-Wide Association Study of Non-Hodgkin Lymphoma,"SKIBOLA, CHRISTINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$513,360"
Lymphoma,2009,NCI,5R01CA085180-09,,Epstein-Barr Virus LMP-1 Mediated Oncogenicity,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$725,501"
Lymphoma,2009,NCI,5R37CA057138-19,,MYC ONCOPROTEIN FUNCTION,"EISENMAN, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$837,221"
Lymphoma,2009,NCI,5R01CA089194-09,,Jak/STAT signaling in human T-cell lymphomas,"WASIK, MARIUSZ",UNIVERSITY OF PENNSYLVANIA,PA,"$249,891"
Lymphoma,2009,NCI,5R01CA047006-22,,Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$560,086"
Lymphoma,2009,NCI,5R01CA104596-05,,Expression and Function of Tob in T Lymphocytes,"BOUSSIOTIS, VASSILIKI",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$318,352"
Lymphoma,2009,NCI,5R01CA112211-03,,SPONTANEOUS CANINE MODELS FOR CANCER GENE DISCOVERY,"BREEN, MATTHEW",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$282,300"
Lymphoma,2009,NCI,5K22CA128882-03,,Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis,"CAREY, GREGORY",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$167,400"
Lymphoma,2009,NCI,5R01CA124596-02,,Oncogenes and oncogenic microRNAs in chicken tumors,"BEEMON, KAREN",JOHNS HOPKINS UNIVERSITY,MD,"$335,272"
Lymphoma,2009,NCI,1F32CA139883-01,,The role of miR-155 in cell cycle regulation and tumorigenesis,"SO, ALEX",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$47,210"
Lymphoma,2009,NCI,2R01CA098495-06A2,,The Regulation of Somatic Hypermutation,"PAPAVASILIOU, F.",ROCKEFELLER UNIVERSITY,NY,"$273,989"
Lymphoma,2009,NCI,5R13CA124293-04,,Annual Primary CNS Lymphoma Collaborative Group Meeting,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$5,000"
Lymphoma,2009,NCI,5R01CA135531-02,,Inflammation-regulated microRNA in B cell lymphoma,"RICKERT, ROBERT",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$358,457"
Lymphoma,2009,NIGMS,1F32GM083438-01A2,,Structural Analysis of DNA Replication Machinery of P. falciparum,"LINDNER, SCOTT",UNIVERSITY OF WISCONSIN MADISON,WI,"$24,460"
Lymphoma,2009,NCI,1F32CA139868-01,,Development of a Pd Catalyzed 3+2 Annulation and Synthesis of Daphnicyclidin B,"MANNING, JAMES",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$47,210"
Lymphoma,2009,NCI,5K01CA122192-03,,Cooperation of PTEN and SHIP as tumor suppressors in B-Cells,"PEDERSEN, IRENE",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$110,843"
Lymphoma,2009,NCI,5K08CA118260-04,,CD20 DNA VACCINATION FOR B-CELL LYMPHOMA,"PALOMBA, MARIA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$134,622"
Lymphoma,2009,NCI,5R01CA122105-03,,Prognostic Models in Diffuse Large B-Cell Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$315,308"
Lymphoma,2009,NCI,5K24CA128953-02,,Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$164,476"
Lymphoma,2009,NCI,5R01CA127433-03,,Signal transduction inhibitor therapy for Lymphoma,"WITZIG, THOMAS","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$336,563"
Lymphoma,2009,NIAID,5K25AI079404-02,,Light Weight Modeling of Epstein Barr Virus,"SHAPIRO, MICHAEL",TUFTS UNIVERSITY BOSTON,MA,"$124,632"
Lymphoma,2009,NCI,5R44CA108083-03,,An anti-CD74 MAb-drug conjugate for B-cell malignancies,"GOVINDAN, SERENGULAM","IMMUNOMEDICS, INC.",NJ,"$309,824"
Lymphoma,2009,NCI,5K08CA127353-02,,Epigenetic Mechanisms of Lymphomagenesis.,"SHAKNOVICH, RITA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$138,672"
Lymphoma,2009,NCI,5R01CA137488-15,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$495,178"
Lymphoma,2009,NCI,5R01CA127530-02,,The role of protein kinase PKK in BAFF signaling and B-cell malignancies,"ZHAO, JIYONG",UNIVERSITY OF ROCHESTER,NY,"$319,550"
Lymphoma,2009,NCI,5R01CA124540-02,,Multiple Roles of the API2 Moiety in API2-MALT1-Mediated Lymphomagenesis,"MCALLISTER-LUCAS, LINDA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$319,190"
Lymphoma,2009,NCI,5R01CA129962-02,,Heat shock protein 90 antagonist-based therapy of mantle cell lymphoma,"BHALLA, KAPIL",MEDICAL COLLEGE OF GEORGIA (MCG),GA,"$305,025"
Lymphoma,2009,NCI,5R01CA122569-02,,Toll Receptor Ligand Therapy of Cutaneous T-Cell Lymphoma,"ROOK, ALAIN",UNIVERSITY OF PENNSYLVANIA,PA,"$269,612"
Lymphoma,2009,NCI,5R01CA112217-04,,Targeting of EBV Latency in Burkitt's Lymphoma,"RAMOS, JUAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$236,524"
Lymphoma,2009,NCI,5R03CA136064-02,,Outcomes of Curable Cancers in Vulnerable Populations,"KOROUKIAN, SIRAN",CASE WESTERN RESERVE UNIVERSITY,OH,"$54,950"
Lymphoma,2009,NCI,5R21CA128560-02,,Role of Cyclooxygenase-2 and PGE2 in KSHV pathogenesis,"SHARMA-WALIA, NEELAM",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$190,575"
Lymphoma,2009,NIAID,5R03AI079797-02,,Investigations into XIAP-deficient X-linked Lymphoproliferative Disease,"MARSH, REBECCA",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$75,000"
Lymphoma,2009,NCI,5R01CA116481-03,,The Role of Fbxw7 in genetic instability and cancer,"MAO, JIAN-HUA",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$355,982"
Lymphoma,2009,NCI,5R03CA137828-02,,Hodgkin Lymphoma Consortium: Pooling epidemiologic data for a research resource,"GLASER, SALLY",NORTHERN CALIFORNIA CANCER CENTER,CA,"$72,500"
Lymphoma,2009,NCI,5R03CA137757-02,,Relationship of 6 (Q)(22) to Survival in Primary CNS Lymphoma,"O'NEILL, BRIAN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$75,550"
Lymphoma,2009,NCI,5R01CA092104-06,,Biologic Therapy for B-cell non-Hodgkin's Lymphoma,"ANSELL, STEPHEN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$258,741"
Lymphoma,2009,NCRR,5R24RR023343-03,,Herpesvirus latency and reactivation in macaque models of human disease,"ROSE, TIMOTHY",SEATTLE CHILDREN'S HOSPITAL,WA,"$591,733"
Lymphoma,2009,NIAID,5R21AI076747-02,,Exploring the Mechanisms of 53BP1-driven Immune Deficiency and DNA Repair,"CARPENTER, PHILLIP",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$186,145"
Lymphoma,2009,NCI,5R01CA134234-02,,Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$503,454"
Lymphoma,2009,NCI,5R21CA132279-02,,EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response,"POSNER, MARSHALL",DANA-FARBER CANCER INSTITUTE,MA,"$370,980"
Lymphoma,2009,NCI,5R01CA092153-07,,Molecular Epidemiology of NHL and CLL,"CERHAN, JAMES","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$635,856"
Lymphoma,2009,NCI,5R01CA130826-02,,Software & Hardware Inference Engines for Automated Determination of Primary Cell,"NOLAN, GARRY",STANFORD UNIVERSITY,CA,"$1,676,305"
Lymphoma,2009,NCI,5F32CA130469-02,,The role of cellular miRNA in Epstein-Barr virus oncogenesis,"CAMERON, JENNIFER",TULANE UNIVERSITY OF LOUISIANA,LA,"$55,310"
Lymphoma,2009,NIAID,2R15AI070249-02,,Function of Pax5 Isoforms during B Cell Development and Activation,"ZWOLLO, PATTY",COLLEGE OF WILLIAM AND MARY,VA,"$211,600"
Lymphoma,2009,NCI,1R21CA141094-01,,Improved idiotype immunotherapy for lymphoma by RNA vaccine delivery,"MCCORMICK, ALISON",TOURO UNIVERSITY OF CALIFORNIA,CA,"$168,300"
Lymphoma,2009,NCI,1K99CA140728-01,,Immunotransplant to Treat Lymphoma: Pre-Clinical Model to Clinical Trial Design,"BRODY, JOSHUA",STANFORD UNIVERSITY,CA,"$173,448"
Lymphoma,2009,NCI,1K08CA140718-01,,Regulation and Dysregulation of Antibody Diversification,"STROUT, MATTHEW",YALE UNIVERSITY,CT,"$174,420"
Lymphoma,2009,NCI,1P50CA136411-01A1,5412,Epigenetic-based therapy of Hodgkin lymphoma,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$69,091"
Lymphoma,2009,NCI,1P50CA136411-01A1,5414,Development of 8-chloro-adenosine therapy,"GANDHI, VARSHA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$69,272"
Lymphoma,2009,NCI,1P50CA136411-01A1,5415,Non-genotoxic p53 activation as novel therapeutic concept for lymphoma,"ANDREEFF, MICHAEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$67,984"
Lymphoma,2009,NCI,1P50CA136411-01A1,5416,Gene expression profiling and pathway targeted therapy in peripheral T-cell,"CHAN, WING",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$102,970"
Lymphoma,2009,NCI,1P50CA136411-01A1,5417,Administrative Core,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,677"
Lymphoma,2009,NCI,1P50CA136411-01A1,5419,Biospecimen Core,"MEDEIROS, L",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,678"
Lymphoma,2009,NCI,1P50CA136411-01A1,5421,Clinical Research Core,"YOUNES, ANAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,650"
Lymphoma,2009,NCI,1P50CA136411-01A1,5425,Biostatistics and Bioinformatics Core,"BERRY, DONALD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$47,678"
Lymphoma,2009,NCI,2P01CA016038-36,7648,Biology of the Epstein-Barr Virus R Transactivator in Human B Cells,"MILLER, I.",YALE UNIVERSITY,CT,"$407,823"
Lymphoma,2009,NCI,2P01CA016038-36,7650,"Viral RNPs, mRNA Stability and Export","STEITZ, JOAN",YALE UNIVERSITY,CT,"$183,551"
Lymphoma,2009,NCI,1P01CA128115-01A2,7661,Host Defense Regulation by HTLV-1,"ROSENBLATT, JOSEPH",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$260,199"
Lymphoma,2009,NCI,2R01CA109335-04A1,,Significance and Function of HGAL in Lymphoma,"LOSSOS, IZIDORE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$263,946"
Lymphoma,2009,NCI,1R01CA134451-01A1,,Computer-assisted Grading and Risk Stratification of Follicular Lymphoma,"GURCAN, METIN",OHIO STATE UNIVERSITY,OH,"$320,633"
Lymphoma,2009,NIAAA,1R01AA017972-01A1,,Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction,"GARTENHAUS, RONALD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$356,250"
Lymphoma,2009,NCI,4R00CA126186-03,,Functions of microRNAs in lymphomagenesis,"HE, LIN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$223,256"
Lymphoma,2009,NIAID,1R21AI081224-01A1,,Long-Range Genetic and Epigenetic Control of Tcrb Gene Assembly,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$190,000"
Lymphoma,2009,NCI,1R01CA132098-01A2,,HDAC Inhibitors and CTCL,"SHOWE, LOUISE",WISTAR INSTITUTE,PA,"$415,059"
Lymphoma,2009,NCI,1R21CA133963-01A2,,Murine Models for Mantle Cell Lymphoma:  The role of tumor initiating cells (TIC),"FORD, RICHARD",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$169,400"
Lymphoma,2009,NIAID,1R01AI078234-01A2,,New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome,"MIKOVITS, JUDY",WHITTEMORE PETERSON INSTITUTE,NV,"$335,600"
Lymphoma,2009,RMAP,1R21NS064746-01A1,,HTS to Identify Novel Chemical Probes for CCR6,"ROTH, GREGORY",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$191,000"
Lymphoma,2009,NCI,1R01CA139083-01A1,,The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's Lymphoma,"RUBENSTEIN, JAMES",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$319,759"
Lymphoma,2009,NIAID,1R01AI078267-01A2,,Transcriptional Control of Hematopoiesis,"KEE, BARBARA",UNIVERSITY OF CHICAGO,IL,"$390,000"
Lymphoma,2009,NCI,1R43CA141754-01,,Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy,"ROSSI, EDMUND","IMMUNOMEDICS, INC.",NJ,"$133,835"
Lymphoma,2009,NCI,1R44CA139668-01A1,,Combined radio- and immunotherapy of aggressive NHL,"WEGENER, WILLIAM","IMMUNOMEDICS, INC.",NJ,"$859,792"
Lymphoma,2009,NCI,1R43CA141842-01,,Optimize RNA-aptamer for Biomarker Molecule CD30,"YANG, XIANBIN","AM BIOTECHNOLOGIES, LLC",TX,"$123,605"
Lymphoma,2009,NIAID,1R43AI079928-01A2,,Novel Inhibitors of Latent Epstein Barr Virus Infection,"MESSICK, TROY","VIRONIKA, LLC",PA,"$192,557"
Lymphoma,2009,NCI,1R43CA141904-01,,Nanobiotechnology for the Treatment of Mantle Cell Lymphoma,"FORTE, TRUDY","LYPRO BIOSCIENCES, INC.",CA,"$109,354"
Lymphoma,2009,NCI,1R03CA134159-01A2,,Enhanced Self-Appraisal After Cancer:  A Bias in Survivors' Self-Report?,"RECKLITIS, CHRISTOPHER",DANA-FARBER CANCER INSTITUTE,MA,"$84,552"
Lymphoma,2009,NCI,2R01CA103642-06A1,,Immune surveillance in murine gammaherpesvirus infection,"USHERWOOD, EDWARD",DARTMOUTH COLLEGE,NH,"$432,673"
Lymphoma,2009,NCI,1R01CA134241-01A2,,Post-Translational Events Underlying the KSHV vGPCR Pathogenesis,"FENG, PINGHUI",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$313,948"
Lymphoma,2009,NCI,2R01CA058853-16A2,,Regulation of EBV Infection in Epithelial Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$293,684"
Lymphoma,2009,NIGMS,3F32GM076816-02S1,,Organocatalytic Asymmetric Cascade Reactions,"NICEWICZ, DAVID",PRINCETON UNIVERSITY,NJ,"$24,602"
Lymphoma,2009,NCI,5P01CA113239-04,0003,P-3:Viral Chemokine signalling in HHV-8 infection,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$302,802"
Lymphoma,2009,RMAP,1R03DA028853-01,,Discovery of inhibitors of anti-apoptotic protein A1,"GOLUB, TODD","BROAD INSTITUTE, INC.",MA,"$25,000"
Lymphoma,2009,NCI,1R01CA138268-01A2,,"Role of the cellular microRNA, miR-155, in EBV type III latency signaling","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$309,175"
Lymphoma,2009,NIAID,1R01AI085024-01,,Gene and Cytokine Expression in Tolerance and GVHD,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$400,000"
Lymphoma,2009,NCI,1K99CA143231-01,,Targeting the B Cell Receptor Signaling Network in Lymphoma,"IRISH, JONATHAN",STANFORD UNIVERSITY,CA,"$136,161"
Lymphoma,2009,NCI,5P01CA015396-34,0020,Hodgkin's Lymphoma Stem Cells,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$362,695"
Lymphoma,2009,NCI,1K01CA138559-01A1,,Antibody-mediated Gene Therapy for the Treatment of Cancer,"DANIELS, TRACY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$136,347"
Lymphoma,2009,NCI,5P01CA013106-38,0007,Regulation of Pre-mRNA Splicing in Tumorigenesis,"KRAINER, ADRIAN",COLD SPRING HARBOR LABORATORY,NY,"$600,387"
Lymphoma,2009,NCI,5P01CA013106-38,0027,microRNAs in Human Cancer,"HANNON, GREGORY",COLD SPRING HARBOR LABORATORY,NY,"$648,078"
Lymphoma,2009,NCI,5P01CA013106-38,0028,Tumor Suppression,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$713,324"
Lymphoma,2009,NCI,5P01CA034233-25,0032,In Situ Vaccination for Lymphoma by Intratumoral Injection of Immunostimulatory,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$409,943"
Lymphoma,2009,NCI,5P01CA034233-25,0033,Intracellular Signaling in Malignant Lymphoma Cells,"NOLAN, GARRY",UNIVERSITY OF MIAMI CORAL GABLES,FL,"$395,892"
Lymphoma,2009,NCI,5P01CA034233-25,0034,Immune Status and Tumor Regression Upon Oncogene Inactivation,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$377,520"
Lymphoma,2009,NCI,5P01CA034233-25,9002,"Diagnosis, Tissue Acquisition, Banking Distribution","LEVY, RONALD",STANFORD UNIVERSITY,CA,"$212,810"
Lymphoma,2009,NCI,5P01CA034233-25,9003,Statistics and Data Management,"TIBSHIRANI, ROBERT",STANFORD UNIVERSITY,CA,"$321,536"
Lymphoma,2009,NCI,5P01CA049605-21,0001,Allografting for Lukemia,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$244,175"
Lymphoma,2009,NCI,5P01CA049605-21,0002,Autografting for Lymphoma,"HORNING, SANDRA",STANFORD UNIVERSITY,CA,"$382,673"
Lymphoma,2009,NCI,5P01CA049605-21,0010,Non-Myeloablative Host Conditioning that Protects Against GVHD,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$320,160"
Lymphoma,2009,NCI,5P01CA049605-21,0014,Control of GVHD with Retained GVT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$254,789"
Lymphoma,2009,NCI,5P01CA049605-21,0015,Transplantation of Purified Hematopoietic Cell Populations Acroos Allogenic Barie,"SHIZURU, JUDITH",STANFORD UNIVERSITY,CA,"$272,664"
Lymphoma,2009,NCI,5P01CA049605-21,0017,Improving Immune Reconstitution via Cytokine-Mediated Expansion of Transplanted,"WEINBERG, KENNETH",STANFORD UNIVERSITY,CA,"$304,844"
Lymphoma,2009,NCI,5P01CA049605-21,0018,Protective Immunity Against Herpesvirus Infections,"ARVIN, ANN",STANFORD UNIVERSITY,CA,"$204,551"
Lymphoma,2009,NCI,5P01CA049605-21,9001,Biostatistics and Data Management Core,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$484,537"
Lymphoma,2009,NCI,5P01CA049605-21,9002,Cellular Imaging and Molecular Pathology,"CONTAG, CHRISTOPHER",STANFORD UNIVERSITY,CA,"$334,956"
Lymphoma,2009,NCI,5P01CA049605-21,9003,Cell Processing and Sample Distribution,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$506,830"
Lymphoma,2009,NCI,5P50CA094056-09,0003,Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$292,715"
Lymphoma,2009,NHLBI,5P01HL065608-09,0005,Stat3 in Post-Ischemic Myocardial Inflammation,"BECKER, LEWIS",JOHNS HOPKINS UNIVERSITY,MD,"$383,323"
Lymphoma,2009,NCI,5P01CA019014-31,0021,TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2),"RAAB-TRAUB, NANCY",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$360,885"
Lymphoma,2009,NCI,5P01CA019014-31,0023,CELLULAR AND VIRAL REGULATION OF TYPE III EBV LATENCY,"PAGANO, JOSEPH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$345,354"
Lymphoma,2009,NCI,3R01CA111807-05S1,,The Role of Toll-Like Receptors in Cancer Immunotherapy,"YANG, YIPING",DUKE UNIVERSITY,NC,"$55,452"
Lymphoma,2009,NCI,5P01CA022443-32,0010,Inhibiting The Survival And Proliferation Of EBV-Associated Tumor Cells,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN MADISON,WI,"$364,363"
Lymphoma,2009,NCI,5P01CA022443-32,0012,Plasmid Replicons of Human Tumor Viruses,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN MADISON,WI,"$362,546"
Lymphoma,2009,NCI,5P01CA022443-32,0013,Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio,"MERTZ, JANET",UNIVERSITY OF WISCONSIN MADISON,WI,"$313,680"
Lymphoma,2009,NIDDK,3K01DK080894-02S1,,DNA EXCHANGE DURING STOMACH COLONIZATION BY HELICOBACTER PYLORI,"DORER, MARION",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,080"
Lymphoma,2009,NCI,5P01CA016519-34,0008,REGULATION OF V(D)J RECOMBINATION IN CELL CYCLE AND IN DEVELOPMENT,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$271,588"
Lymphoma,2009,NIA,1F30AG035484-01,,Role of dre-1/FBXO11 in apoptosis,"CHIORAZZI, MICHAEL",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$46,176"
Lymphoma,2009,NIAID,3R01AI041769-12S1,,Cellular Mechanisms of PTLD in Transplant Recipients,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$47,463"
Lymphoma,2009,NCI,5P01CA059350-16,0005,Artif. Antigen Presentation to Sensitize Virus-Spec. TCells for Adoptive Immunoth,"O'REILLY, RICHARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$375,263"
Lymphoma,2009,NCI,5P01CA044991-22,0001,Radiolabeled Antibody Therapy of B-Cell Lymphoma,"GOPAL, AJAY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$95,473"
Lymphoma,2009,NCI,5P01CA044991-22,0006,Improved Targeting Strategies,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$450,632"
Lymphoma,2009,NCI,5P01CA044991-22,9004,Core--Biologics Production,"BALDWIN, JANELL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$128,075"
Lymphoma,2009,NCI,5P30CA124435-03,0016,CANCER IMAGING RESOURCE,"DOYLE, TIMOTHY",STANFORD UNIVERSITY,CA,"$64,669"
Lymphoma,2009,NCI,5P30CA016059-29,9029,Protocol-Specific Research Support,"GINDER, GORDON",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$49,882"
Lymphoma,2009,NCI,5P01CA030206-27,0020,Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and,"FORMA, STEPHEN",CITY OF HOPE NATIONAL MEDICAL CENTER,CA,"$1,070,477"
Lymphoma,2009,RMAP,3R21NS063906-01S2,,Assay For Inhibitors of Epstein-Barr Virus,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$52,125"
Lymphoma,2009,NCI,5P30CA013696-36,0009,LYMPHOID DVLP AND MALIGNANCIES (LDM),"O'CONNOR, OWEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$34,254"
Lymphoma,2009,NCI,3R01CA071768-13S2,,Redox Control of Apoptosis Signaling,"BRIEHL, MARGARET",UNIVERSITY OF ARIZONA,AZ,"$53,073"
Lymphoma,2009,NCI,5P01CA100730-07,0005,Role of Inflammation in Tax-mediated Tumorigenesis,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$412,519"
Lymphoma,2009,NCI,5P01CA100730-07,0006,Role of Bone Microenvironment in Tax Induced Malignancies,"WEILBAECHER, KATHERINE",WASHINGTON UNIVERSITY,MO,"$360,283"
Lymphoma,2009,NCI,5P50CA097274-08,0001,A Novel Approach to the Immunotherapy of B Cell Malignancy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$222,868"
Lymphoma,2009,NCI,5P50CA097274-08,0002,Signal Transduction Inhibitor Therapy for Lymphoma,"WITZIG, THOMAS",UNIVERSITY OF IOWA,IA,"$299,324"
Lymphoma,2009,NCI,5P50CA097274-08,0003,Biology and Epidemiology of APRIL and Blys in B-cell and NHL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$425,295"
Lymphoma,2009,NCI,5P50CA097274-08,0004,Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$277,767"
Lymphoma,2009,NCI,5P50CA097274-08,0005,Developmental Research Program,"RATLIFF, TIMOTHY",UNIVERSITY OF IOWA,IA,"$170,331"
Lymphoma,2009,NCI,5P50CA097274-08,0006,Career Development Program,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$93,469"
Lymphoma,2009,NCI,5P50CA097274-08,9001,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$268,572"
Lymphoma,2009,NCI,5P50CA097274-08,9002,Biostatistics and Bioinformatics,"GEYER, SUSAN",UNIVERSITY OF IOWA,IA,"$167,075"
Lymphoma,2009,NCI,5P50CA097274-08,9003,Clinical Research,"LINK, BRIAN",UNIVERSITY OF IOWA,IA,"$327,251"
Lymphoma,2009,OD,2R56CA108447-06,,Immune Evasion by KSHV,"COSCOY, LAURENT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$232,636"
Lymphoma,2009,NCI,3R01CA088768-10S1,,Structure and Molecular Composition of KSHV an RRV,"KEDES, DEAN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$52,863"
Lymphoma,2009,NCI,3R01CA088768-10S2,,Structure and Molecular Composition of KSHV an RRV,"KEDES, DEAN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$52,316"
Lymphoma,2009,NCI,5P30CA013330-37,9032,IMMUNO-ONCOLOGY,"SCHARFF, MATTHEW",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$36,323"
Lymphoma,2009,OD,2R56CA104348-06,,Trancriptional silencing by the Bcl-6 Oncoprotein,"MELNICK, ARI",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$267,478"
Lymphoma,2009,NCI,5P01CA033049-26,0016,Strategies to Enhance Post-Transplant Tumor Vaccination,"VAN DEN BRINK, MARCEL",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$326,165"
Lymphoma,2009,NCI,5U54CA119367-04,0005,Biological Modification of Quantum Dots for in vivo Imaging,"WU, ANNA",STANFORD UNIVERSITY,CA,"$487,188"
Lymphoma,2009,NCI,5U54CA119367-04,0006,Mouse Cancer Models for Integrated Tissue/Serum Proteomics and Molecular Imaging,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$667,466"
Lymphoma,2009,NCI,3R01CA109524-04S1,,IL-7 and Lymphocyte Homeostasis: Life versus Death,"KHALED, ANNETTE",UNIVERSITY OF CENTRAL FLORIDA,FL,"$43,120"
Lymphoma,2009,NCI,5P01CA092625-09,0006,Molecular Mechanism of Translocations in B-Cell Lymphoma,"ALT, FREDERICK",DANA-FARBER CANCER INSTITUTE,MA,"$507,327"
Lymphoma,2009,NCI,5P01CA092625-09,0007,"The Role of B-Cell Receptor and NF
                                    RAJEWSKY, KLAUS
                                
                                    DANA-FARBER CANCER INSTITUTE
                                
                                    MA
                                
                                    $475,756","RAJEWSKY, KLAUS",DANA-FARBER CANCER INSTITUTE,MA,"$475,756"
Lymphoma,2009,NCI,5P01CA092625-09,0008,The Role of BCL-6 in Berminal Center Formation,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$473,903"
Lymphoma,2009,NCI,5P01CA092625-09,0009,Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom,"SHIPP, MARGARET",DANA-FARBER CANCER INSTITUTE,MA,"$349,556"
Lymphoma,2009,NCI,5P01CA092625-09,0010,Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma,"WALENSKY, LOREN",DANA-FARBER CANCER INSTITUTE,MA,"$368,077"
Lymphoma,2009,NCI,5P01CA092625-09,0011,Genomics and Bioinformatics,"GOLUB, TODD",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$388,748"
Lymphoma,2009,NCI,5P01CA092625-09,0012,Hematopathology,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$433,164"
Lymphoma,2009,NCI,5P01CA092625-09,0013,Biostatistics and Clinical Trials,"NEUBERG, DONNA",DANA-FARBER CANCER INSTITUTE,MA,"$205,933"
Lymphoma,2009,NCI,5P01CA092625-09,9005,Administrative,"SHIPP, MARGARET",DANA-FARBER CANCER INSTITUTE,MA,"$114,354"
Lymphoma,2009,NCI,5U19CA113298-05,0001,Optimization and Characterization of Targeting Agents for Lymphoid Malignancies,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$410,075"
Lymphoma,2009,NCI,5U19CA113298-05,0002,Characterization of Targeting Ligands-Integrin Interaction and in vitro targeting,"TAKADA, YOSHIKAZU",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$185,430"
Lymphoma,2009,NCI,5U19CA113298-05,0003,"Lymphoma-Specific Ligands; Pharmacokinetics, Radioimaging and Therapeutics","DENARDO, SALLY",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$342,735"
Lymphoma,2009,NCI,5U19CA113298-05,9001,Core--Synthetic Chemistry,"KURTH, MARK",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$175,314"
Lymphoma,2009,NCI,3U56CA112973-03S3,,Computational Modeling of Cancer Biology,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$251,158"
Lymphoma,2009,NCI,5P50CA086438-09,0005,Imaging T Cell Interactions in Adoptive Therapy of EBV-Associated Malignancies,"BLASBERG, RONALD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$223,946"
Lymphoma,2009,NCI,5P50CA086438-09,0010,Developmental Research Program,"JURCIC, JOSEPH",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$159,080"
Lymphoma,2009,NCI,5P01CA087497-09,0003,p53 and Chemosensitivity in a Mouse Lymphoma Model,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$406,228"
Lymphoma,2009,NCI,5P50CA130805-02,0001,P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas,"MAHADEVAN, DARUKA",UNIVERSITY OF ARIZONA,AZ,"$328,078"
Lymphoma,2009,NCI,5P50CA130805-02,0002,Project 2: Optimizing Redox Modulation as a Therapeutic Strategy for NHL,"BERNSTEIN, STEVEN",UNIVERSITY OF ROCHESTER,NY,"$257,420"
Lymphoma,2009,NCI,5P50CA130805-02,0003,P-3:  Potentiating Proteasome Inhibitor Activity in non-Hodgkin's Lymphoma (NHL),"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$377,441"
Lymphoma,2009,NCI,5P50CA130805-02,0004,P-4: Characterization of Lymphoma-Initiating Cells,"JORDAN, CRAIG",UNIVERSITY OF ROCHESTER,NY,"$237,315"
Lymphoma,2009,NCI,5P50CA130805-02,0005,Developmental Research Program,"LAND, HARTMUT",UNIVERSITY OF ROCHESTER,NY,"$67,698"
Lymphoma,2009,NCI,5P50CA130805-02,0006,Career Development Program,"FISHER, SUSAN",UNIVERSITY OF ROCHESTER,NY,"$89,468"
Lymphoma,2009,NCI,5P50CA130805-02,9001,CB: Tissue Core,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$363,518"
Lymphoma,2009,NCI,5P50CA130805-02,9002,CC: Clinical Trials Core,"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$436,725"
Lymphoma,2009,NCI,5P50CA130805-02,9003,CD: Biostatistics Core,"PETERSON, DERICK",UNIVERSITY OF ROCHESTER,NY,"$182,777"
Lymphoma,2009,NCI,5P50CA130805-02,9004,CA: Administration Core,"FISHER, RICHARD",UNIVERSITY OF ROCHESTER,NY,"$281,130"
Lymphoma,2009,NCI,5P01CA042063-24,0011,Cancer and Gene Regulation by Short RNAs,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$481,101"
Lymphoma,2009,NIGMS,7F32GM083438-02,,Structural Analysis of DNA Replication Machinery of P. falciparum,"LINDNER, SCOTT",SEATTLE BIOMEDICAL RESEARCH INSTITUTE,WA,"$25,594"
Lymphoma,2009,NCI,3U56CA112973-03S4,,Computational Modeling of Cancer Biology,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$240,000"
Lymphoma,2009,NCI,3K22CA111639-03S1,,Using the Allergic Immune System to Target Cancer,"MOLLICK, JOSEPH",STANFORD UNIVERSITY,CA,"$10,667"
Lymphoma,2009,NCI,5P01CA095426-08,0005,INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$492,345"
Lymphoma,2009,NCI,5P01CA095426-08,9003,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$247,666"
Lymphoma,2009,NCI,5P30CA016359-31,0003,Research Programs-Immunology and Immunotherapy,"MELLMAN, IRA",YALE UNIVERSITY,CT,"$30,004"
Lymphoma,2009,NCI,4R00CA131474-03,,Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells,"NEILSON, JOEL",BAYLOR COLLEGE OF MEDICINE,TX,"$249,000"
Lymphoma,2009,NCI,5P50CA100707-07,0009,P-5: Molecular markers of plasma cell neoplasm evolution,"FONSECA, RAFAEL","MAYO CLINIC COLL OF MED, MAYO CLINIC AZ",AZ,"$258,694"
Lymphoma,2009,NCI,3R01CA068328-12S1,,c-Myc Expression during Lymphomagenesis,"RUDDELL, M",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$50,292"
Lymphoma,2009,NCI,5P50CA121973-02,0005,Augmentation of Dendritic Cell-based Immunotherapy for Sezary Syndrome by T-reg D,"FALO, LOUIS",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$201,152"
Lymphoma,2009,NCI,5P50CA093683-07,0008,"SPORE Core 1: Administrative, Evaluation and Planning","MARASCO, WAYNE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$279,688"
Lymphoma,2009,NCI,5P50CA126752-03,0001,Immunotherapy for Hodgkin's Disease,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$287,534"
Lymphoma,2009,NCI,5P50CA126752-03,0002,Chimeric T Cell Antigens Targeting Kappa in B Cell Lymphoma,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$299,207"
Lymphoma,2009,NCI,5P50CA126752-03,0003,T Cell Therapy Targeting LMP1 and 2 in EBV+VE Lymphomas,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$300,261"
Lymphoma,2009,NCI,5P50CA126752-03,0004,Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy,"RONGFU, WANG",BAYLOR COLLEGE OF MEDICINE,TX,"$300,320"
Lymphoma,2009,NCI,5P50CA126752-03,0005,Targeting Malignant Stem Cells in CLL,"GOODELL, MARGARET",BAYLOR COLLEGE OF MEDICINE,TX,"$294,221"
Lymphoma,2009,NCI,5P50CA126752-03,0006,Research Development,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$185,587"
Lymphoma,2009,NCI,5P50CA126752-03,0007,Career Development,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$185,587"
Lymphoma,2009,NCI,5P50CA126752-03,9001,Clinical Research Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$83,249"
Lymphoma,2009,NCI,5P50CA126752-03,9002,Biostatistics and Data Management,"WEISS, HEIDI",BAYLOR COLLEGE OF MEDICINE,TX,"$143,706"
Lymphoma,2009,NCI,5P50CA126752-03,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$176,046"
Lymphoma,2009,NCI,5P50CA126752-03,9004,Tissue Resource,"GRESIK, VICTORIA",BAYLOR COLLEGE OF MEDICINE,TX,"$382,841"
Lymphoma,2009,NCI,3P50CA096888-05S2,,SPORE in Lymphoma,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$304,005"
Lymphoma,2009,NCI,3P01CA103985-04S1,,Targeted Therapy of B-cell Malignancies,"GOLDENBERG, DAVID",CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY,NJ,"$519,832"
Lymphoma,2009,NIAID,1R56AI071239-01A2,,Functions of Bcl10 in Lymphocytes,"WEN, RENREN","BLOODCENTER OF WISCONSIN, INC.",WI,"$407,500"
Lymphoma,2009,NCI,7R01CA117802-05,,MYC-induced breach of B-cell anergy in AIDS-related NHLs,"REFAELI, YOSEF",UNIVERSITY OF COLORADO DENVER,CO,"$361,101"
Lymphoma,2009,NCI,3P50CA107399-05S1,,City of Hope Lymphoma SPORE,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$1,079,832"
Lymphoma,2009,NCI,5U54CA119343-05,0002,"""Smart"" Nanoparticles for Cancer Therapy and Imaging","DESIMONE, JOSEPH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$325,649"
Lymphoma,2009,NCI,3R21CA138373-01S2,,Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago,"YIN, HANG",UNIVERSITY OF COLORADO AT BOULDER,CO,"$49,535"
Lymphoma,2009,NCI,3R21CA138373-01S1,,Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago,"YIN, HANG",UNIVERSITY OF COLORADO AT BOULDER,CO,"$45,604"
Lymphoma,2009,NCI,3P50CA093372-07S3,,SPORE in Skin Cancer,"HERLYN, MEENHARD",WISTAR INSTITUTE,PA,"$1,146,135"
Lymphoma,2009,NCI,5P50CA128346-02,0004,Developmental Projects,"MATTREY, ROBERT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$187,555"
Lymphoma,2009,NHLBI,268200900008C-1-0-1,,BIOMEDICAL (BASIC),"DEROOS, ANNECLAIRE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$509,988"
Lymphoma,2009,NCRR,5M01RR000188-45,5986,CLINICAL TRIAL: ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECIFIC C,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,$296
Lymphoma,2009,NCRR,5M01RR000188-45,5987,CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$1,185"
Lymphoma,2009,NCRR,5M01RR000188-45,5991,CLINICAL TRIAL: EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR EBV-POSITIVE NASOPHARYN,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$3,851"
Lymphoma,2009,NCRR,5M01RR000188-45,5996,CLINICAL TRIAL: NEOMYCIN RESISTANCE LMP2A SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR E,"BOLLARD, CATHERINE",BAYLOR COLLEGE OF MEDICINE,TX,"$26,959"
Lymphoma,2009,NCRR,5M01RR000188-45,6005,CLINICAL TRIAL: ADMINISTRATION OF LMP1- AND LMP2-SPECIFIC CYTOTOXIC T-LYMPHOCYTE,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$51,554"
Lymphoma,2009,NCRR,5M01RR010732-15,6545,CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE,"EHMANN, CHRISTOPHER",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,$917
Lymphoma,2009,NCRR,5M01RR010732-15,6563,CLINICAL TRIAL: A RANDOMIZED PHASE III TRIAL OF ABVD VS STANDFORD V+/- RADIATION,"RYBKA, WITOLD",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$3,235"
Lymphoma,2009,NCRR,5M01RR010732-15,6592,CLINICAL TRIAL: PI & PHARMACOKINETIC STUDY OF DRUG FOR SOLID TUMORS & LYMPHOMAS,"BELANI, CHANDRA",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,$925
Lymphoma,2009,NCRR,5M01RR010732-15,6668,CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE,"EHMANN, CHRISTOPHER",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,$925
Lymphoma,2009,NCRR,5M01RR000865-36,6883,"A PHASE II TRIAL OF DOXIL, RITUXIMAB, CYCLOPHOSPHAMIDE,","MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$13,215"
Lymphoma,2009,NCRR,5M01RR000865-36,6885,SHORT COURSE REGIMEN (R-CODOX-M/IVAC) I,"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$7,343"
Lymphoma,2009,NCRR,5M01RR000400-41,6965,CLINICAL TRIAL: MT2003-03 CPG 7909 AFTER AUTOLOGOUS TRANSPLANTATION TO ENHANCE R,"TOMBLYN, MARCIE",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,463"
Lymphoma,2009,NCRR,5M01RR000400-41,7073,MT2007-12: ALLOGENEIC NATURAL KILLER CELLS WITH RITUXIMAB IN PATIENTS WITH CD20,"BACHANOVA, VERONIKA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,463"
Lymphoma,2009,NCI,N01PC35135-22-0-5,,SEER RRSS #2:  Frequency and Predictors of Missing Data in Site-Specific Variable,"WARD, KEVIN",EMORY UNIVERSITY,GA,"$74,228"
Lymphoma,2009,NCI,N01PC35139-25-0-11,,#14:  Residual Tissue Repository to Create HIV Cancer Tumor Tissue Microrarrays,"DEAPEN, DENNIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$241,675"
Lymphoma,2009,NCRR,5P41RR015301-07,5384,"CRYSTAL STRUCTURE OF THE KSHV PROCESSIVITY FACTOR, PF-8","HOGLE, JAMES",CORNELL UNIVERSITY ITHACA,NY,"$21,951"
Lymphoma,2009,NCRR,5P41RR009784-15,5637,DETECTION OF NADH REDUCTASE KINETICS WITH [1-13C]-PYRUVATE MRSI,"DARPOLOR, MOSES",STANFORD UNIVERSITY,CA,"$18,046"
Lymphoma,2009,NCRR,5P41RR010888-13,6129,BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL,"DENIS, GERALD",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$9,492"
Lymphoma,2009,NCRR,5P41RR013186-12,6623,DEVELOPMENT OF USER GUIDE & TUTORIAL FOR VIRTUAL CELL SOFTWARE,"SCHAFF, JAMES",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$32,549"
Lymphoma,2009,NCRR,5P51RR000165-49,8454,VETERINARY RESIDENCY TRAINING PROGRAM,"ELSE, JAMES",EMORY UNIVERSITY,GA,"$56,690"
Lymphoma,2009,NCRR,5P51RR000168-48,8504,PATHOGENESIS OF EPSTEIN-BARR VIRUS INFECTION,"WANG, FREDERICK",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$111,945"
Lymphoma,2009,NCRR,5P51RR000168-48,8597,GP350 AS A NOVEL VACCINE PROTEIN CARRIER,"SNAPPER, CLIFFORD",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$64,877"
Lymphoma,2009,NCRR,2P51RR000163-50,8607,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$202,088"
Lymphoma,2009,NIA,2P51RR000163-50,8607,RHESUS HHV8 HOMOLOGUE IN AIDS-RELATED MALIGNANCIES,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$4,585"
Lymphoma,2009,NCRR,2P51RR000163-50,8643,VALIDATING VIL-6 AS A TARGET FOR KSHV-ASSOCIATED DISEASE,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$50,422"
Lymphoma,2009,NIA,2P51RR000163-50,8643,VALIDATING VIL-6 AS A TARGET FOR KSHV-ASSOCIATED DISEASE,"WONG, SCOTT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,144"
Lymphoma,2009,NCRR,2P51RR000163-50,8649,THE ROLE OF HIV-1 VPU IN THE REGULATION OF CD40,"MOSES, ASHLEE",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$86,647"
Lymphoma,2009,NIA,2P51RR000163-50,8649,THE ROLE OF HIV-1 VPU IN THE REGULATION OF CD40,"MOSES, ASHLEE",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,966"
Lymphoma,2009,NCRR,5P51RR000166-48,5185,RADIOIMMUNOTHERAPY AND EXTRACORPOREAL ADSORPTION THERAPY STUDIES IN MACAQUES,"PRESS, OLIVER",UNIVERSITY OF WASHINGTON,WA,"$157,595"
Lymphoma,2009,NCRR,5P20RR016456-08,5633,GENETICS AND FUNCTIONS OF KSHV GLYCOPROTEINS GM AND GN,"D'AUVERGNE, OSWALD",LOUISIANA STATE UNIV A&M COL BATON ROUGE,LA,"$96,135"
Lymphoma,2009,NCRR,5P20RR018724-07,5725,LSUHSC COBRE:  DEFINING BONE MARROW AS A RESERVOIR FOR GAMMAHERPESVIRUS LATENCY,"TIBBETTS, SCOTT",LOUISIANA STATE UNIV HSC SHREVEPORT,LA,"$211,317"
Lymphoma,2009,NCRR,5P20RR018789-07,6566,4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT,"MILLS, KEVIN",MAINE MEDICAL CENTER,ME,"$243,975"
Lymphoma,2009,NIA,1ZIAAG000166-08,,Characterization Of TGF-b Signaling In a B-cell Lymphoma Cell Line,"LONGO, DAN",NIH,,"$367,439"
Lymphoma,2009,NIA,1ZIAAG000451-01,,Role of Hyperplasia Suppressor Gene (HSG) in cell growth.,"LONGO, DAN",NIH,,"$444,794"
Lymphoma,2009,NIA,1ZIAAG000770-06,,Chemoattractant-based immunotherapeutics to modulate immune and cancer cells,"BIRAGYN, ARYA",NIH,,"$183,719"
Lymphoma,2009,NIA,1ZIAAG000983-01,,Long-Term Consequences of Lymphoma and its Treatment,"LONGO, DAN",NIH,,"$48,347"
Lymphoma,2009,NIAID,1ZIAAI000732-15,,"Clinical, Immunological and Genetic  Analyses of ALPS","RAO, VEMULKONDA",NIH,,"$196,334"
Lymphoma,2009,NIAID,1ZIAAI000858-10,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$883,702"
Lymphoma,2009,NIAID,1ZIAAI000913-08,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$618,312"
Lymphoma,2009,NIAID,1ZIAAI000978-04,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$502,485"
Lymphoma,2009,NIAID,1ZIAAI001059-02,,Defining New Human Immunodeficiency and Immunodysregulation Disorders,"SU, HELEN",NIH,,"$770,865"
Lymphoma,2009,NIAID,1ZIAAI001070-02,,Targeted Killing of Herpesvirus-Infected Cells,"BERGER, EDWARD",NIH,,"$329,157"
Lymphoma,2009,NCI,1ZIABC008727-31,,Gene Expression and Signal Transduction in Transformation and Differentiation,"MUSHINSKI, J.",NIH,,"$100,294"
Lymphoma,2009,NCI,1ZIABC009265-27,,Analysis of the T Cell Repertoire,"HODES, RICHARD",NIH,,"$923,719"
Lymphoma,2009,NCI,1ZIABC010008-14,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$448,310"
Lymphoma,2009,NCI,1ZIABC010283-08,,DNA Repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,063,847"
Lymphoma,2009,NCI,1ZIABC010301-12,,Development of Recombinant Toxins to Treat Hematologic Malignancies,"KREITMAN, ROBERT",NIH,,"$683,093"
Lymphoma,2009,NCI,1ZIABC010391-08,,Role of Trk Receptors in the Development and Function of Non-neuronal Structures,"TESSAROLLO, LINO",NIH,,"$581,426"
Lymphoma,2009,NCI,1ZIABC010603-06,,Receptor-directed Therapy,"JANIK, JOHN",NIH,,"$1,253,922"
Lymphoma,2009,NCI,1ZIABC010621-06,,Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,"BATES, SUSAN",NIH,,"$815,865"
Lymphoma,2009,NCI,1ZIABC010652-05,,Lipid-based Nanocapsules and Triggered Chemotherapy,"BLUMENTHAL, ROBERT",NIH,,"$782,351"
Lymphoma,2009,NCI,1ZIABC010715-04,,Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"WILSON, WYNDHAM",NIH,,"$239,245"
Lymphoma,2009,NCI,1ZIABC010716-04,,Phase I/II study of BCL-family inhibitors in lymphoma,"WILSON, WYNDHAM",NIH,,"$239,245"
Lymphoma,2009,NCI,1ZIABC010717-04,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$119,623"
Lymphoma,2009,NCI,1ZIABC010719-04,,Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$119,623"
Lymphoma,2009,NCI,1ZIABC010728-04,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$119,623"
Lymphoma,2009,NCI,1ZIABC010885-02,,Study of tumor pathogenesis and development of therapies for AIDS-malignancies,"YARCHOAN, ROBERT",NIH,,"$688,334"
Lymphoma,2009,NCI,1ZIABC010888-02,,Clinical trials of patients with AIDS-related malignancies,"YARCHOAN, ROBERT",NIH,,"$1,032,501"
Lymphoma,2009,NCI,1ZIABC010911-02,,Role of Novel MicroRNAs in the PVT-1 Locus,"MUSHINSKI, J.",NIH,,"$44,575"
Lymphoma,2009,NCI,1ZIABC010924-02,,Pathogenesis of cutaneous T cell lymphoma,"HWANG, SAM",NIH,,"$60,715"
Lymphoma,2009,NCI,1ZIABC010925-02,,Phase I Study of Topical Romidepsin in Early Stage Cutaneous T-cell Lymphoma,"KONG, HEIDI",NIH,,"$101,020"
Lymphoma,2009,NCI,1ZIABC011006-02,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$800,463"
Lymphoma,2009,NCI,1ZIABC011007-02,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$800,463"
Lymphoma,2009,NCI,1ZIABC011008-02,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$800,463"
Lymphoma,2009,NCI,1ZIABC011064-02,,A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,"MOCK, BEVERLY",NIH,,"$336,233"
Lymphoma,2009,NCI,1ZIABC011070-02,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$711,370"
Lymphoma,2009,NCI,1ZIABC011135-02,,Molecular Mechanisms of Lymphomagenesis,"RAFFELD, MARK",NIH,,"$201,659"
Lymphoma,2009,NCI,1ZIABC011192-01,,The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,"TESSAROLLO, LINO",NIH,,"$644,453"
Lymphoma,2009,NCI,1ZIACP004410-33,,Family Studies,"TUCKER, MARGARET",NIH,,"$7,074,631"
Lymphoma,2009,NCI,1ZIACP005782-15,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$730,797"
Lymphoma,2009,NCI,1ZIACP005803-15,,Genetic Epidemiology,"GOLDSTEIN, ALISA",NIH,,"$749,390"
Lymphoma,2009,NCI,1ZIACP010125-14,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$2,444,433"
Lymphoma,2009,NCI,1ZIACP010127-14,,Etiologic Studies of Diet and Cancer,"SCHATZKIN, ARTHUR",NIH,,"$110,063"
Lymphoma,2009,NCI,1ZIACP010170-09,,Multidisciplinary Studies of Lymphoma,"HARTGE, PATRICIA",NIH,,"$681,891"
Lymphoma,2009,NCI,1ZIACP010176-08,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$2,483,980"
Lymphoma,2009,NCI,1ZIACP010183-07,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$1,793,379"
Lymphoma,2009,NIEHS,1ZIAES102265-03,,Methods and Applications for Population-based Incidence and Mortality Statistics,"DINSE, GREGG",NIH,,"$35,461"
Lymphoma,2009,NEI,1ZIAEY000222-24,,Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases,"CHAN, CHI-CHAO",NIH,,"$1,081,049"
Lymphoma,2009,NEI,1ZIAEY000356-09,,Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis),"NUSSENBLATT, ROBERT",NIH,,"$263,372"
Lymphoma,2009,NEI,1ZIAEY000375-09,,Primary Intraocular Lymphoma and Animal Models,"NUSSENBLATT, ROBERT",NIH,,"$116,374"
Lymphoma,2009,NHLBI,1ZIAHL005076-04,,Molecular Effects of Bortezomib in Mantle Cell Lymphoma,"WIESTNER, ADRIAN",NIH,,"$566,584"
Lymphoma,2009,NCI,1ZIASC000550-29,,Lymphoma Disease Discovery and Defintion,"JAFFE, ELAINE",NIH,,"$711,370"
Lymphoma,2009,NCI,1ZIASC003669-20,,Regulation of Cutaneous Accessory Cell Activity in Health and Disease,"UDEY, MARK",NIH,,"$318,885"
Lymphoma,2009,NCI,1ZIASC004002-40,,IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"WALDMANN, THOMAS",NIH,,"$1,786,679"
Lymphoma,2009,NCI,1ZIASC006741-17,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$358,868"
Lymphoma,2009,NCI,1ZIASC010356-10,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$444,240"
Lymphoma,2009,NCI,1ZIASC010357-09,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,163,601"
Lymphoma,2009,NCI,1ZICBC010548-07,,Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,"FIGG, WILLIAM",NIH,,"$594,718"
Lymphoma,2009,NCI,1ZICBC011029-02,,Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant,"HAKIM, FRANCES",NIH,,"$191,351"
Lymphoma,2009,NCI,1ZICBC011042-02,,Global changes in specific histone modifications in cancer,"LEVENS, DAVID",NIH,,"$132,728"
Lymphoma,2009,NCI,1ZICBC011093-02,,FLow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$384,110"
Lymphoma,2009,NCI,1ZICBC011104-02,,Flow Cytometric Evaluation of Biomarkers,"STETLER-STEVENSON, MARYALICE",NIH,,"$480,138"
Lymphoma,2009,NCI,1ZICSC010353-10,,Experimental Therapeutics of Pediatric Hematopoietic Malignancies,"WAYNE, ALAN",NIH,,"$1,159,275"
Lymphoma,2009,NCI,1ZIDBC010688-05,,Dermatology Consultation Clinic and Clinical Research,"TURNER, MARIA",NIH,,"$1,365,435"
Lymphoma,2009,NCI,1ZIEBC011241-01,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$711,370"
Lymphoma,2009,NCI,1ZIGBC010569-06,,Comparative Oncology Program,"KHANNA, CHAND",NIH,,"$212,109"
Lymphoma,2009,NCI,1ZIGBC010856-03,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$16,074,264"
Lymphoma,2009,NCRR,5M01RR000043-49,8624,A PHASE I STUDY OF BORTEZOMIB AND TEMOZOLOMIDE IN PATIENTS WITH REFRACTORY SOLID,"PORTNOW, JANA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$77,684"
Lymphoma,2009,NCRR,5M01RR000043-49,8638,PILOT STUDY OF SAFETY AND FEASIBILITY OF STEM CELL THERAPY FOR AIDS,"KRISHNAN, AMRITA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$7,569"
